Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of initial use of a fixed
dose combination of aliskiren Hydrochlorothiazide (HCTZ) compared to Hydrochlorothiazide in
older population with Stage 2 systolic hypertension.